2m 2m 2m 2m 2m 2m 2m
MICROBOT MEDICAL (MBOT)
NASDAQ
$1.96-$0.01 (-0.71%)
Price as of Jun 03, 2026 7:59 PM EDT- $136.3MMarket Cap
- -28.62%1-Year Change
- Medical Instruments & SuppliesIndustry
MICROBOT MEDICAL (MBOT)
$1.96-$0.01 (-0.71%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 2.5M +31.42% | 1.9M +4.10% | 1.8M +20.27% | 1.5M 0.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 2.5M +31.42% | 1.9M +4.10% | 1.8M +20.27% | 1.5M 0.00% | |
Sales and Marketing Expense | 8.5M +9,971.43% | 84,000 -47.50% | 160,000 -11.11% | 180,000 +328.57% | |
Research and Development Expense | -6.3M -5.23% | -6.6M +15.83% | -5.7M -26.01% | -7.7M +25.73% | |
Depreciation and Amortization Expense | 47,000 -48.35% | 91,000 -14.15% | 106,000 +3.92% | 102,000 +34.21% | |
Total Operating Expenses | 8.5M +69.37% | 5.0M +20.92% | 4.1M -25.50% | 5.5M +6.55% | |
Operating Profit | -14.7M +26.82% | -11.6M +17.96% | -9.9M -25.80% | -13.3M +16.94% | |
Interest Income | 316,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 316,000 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 1.3M +606.04% | 182,000 -20.18% | 228,000 +4,660.00% | -5,000 -111.36% | |
Income before Taxes | -14.7M +26.82% | -11.6M +17.96% | -9.9M -25.80% | -13.3M +16.94% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | N/A N/A | N/A N/A | -10.7M -18.44% | -13.2M +16.40% | |
Net Income from Continuing Operations Applicable to Common | N/A N/A | N/A N/A | -10.7M -18.44% | -13.2M +16.40% | |
Basic EPS and Net Income | -0.29 -60.27% | -0.73 -30.48% | -1.05 -41.99% | -1.81 +13.84% | |
Diluted EPS and Net Income | -0.29 -60.27% | -0.73 -30.48% | -1.05 -41.99% | -1.81 +13.84% | |
Basic Weighted Average Shares | 45.8M +192.69% | 15.6M +53.38% | 10.2M +40.49% | 7.3M +2.14% | |
Diluted Weighted Average Shares | 45.8M +192.69% | 15.6M +53.38% | 10.2M +40.49% | 7.3M +2.14% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 3.9M +25.63% | 3.1M +26.18% | 2.5M +1.06% | 2.4M -81.90% | |
Short-Term Investments | 74.7M N/A | N/A N/A | 3.9M -32.00% | 5.8M +188.14% | |
Cash and Cash Equivalents and Short-Term Investments | 78.6M +2,423.83% | 3.1M -51.23% | 6.4M -22.15% | 8.2M -47.06% | |
Total Current Assets | 79.8M +1,271.75% | 5.8M -26.54% | 7.9M -10.13% | 8.8M -44.49% | |
Accumulated Depreciation | 152,000 +10.14% | 138,000 -72.01% | 493,000 +27.39% | 387,000 +33.91% | |
Property and Plant and Equipment and Net | 93,000 +16.25% | 80,000 -45.21% | 146,000 -33.94% | 221,000 -9.43% | |
Total Long-Term Assets | 93,000 +16.25% | 80,000 -45.21% | 146,000 -33.94% | 221,000 -9.43% | |
Total Assets | 81.5M +1,252.08% | 6.0M -27.57% | 8.3M -12.69% | 9.5M -43.12% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 3.4M +39.07% | 2.5M -35.02% | 3.8M +82.99% | 2.1M +4.28% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 569,000 +1,287.80% | 41,000 +2.50% | 40,000 -77.65% | 179,000 -55.47% | |
Total Liabilities | 4.0M +59.54% | 2.5M -34.63% | 3.8M +70.20% | 2.2M -5.78% | |
Retained Earnings | -104.1M +14.45% | -90.9M +14.39% | -79.5M +15.62% | -68.8M +23.69% | |
Total Stockholders Equity | 77.6M +2,097.00% | 3.5M -21.57% | 4.5M -38.25% | 7.3M -49.32% | |
Total Shares Outstanding | 67.2M +246.18% | 19.4M +65.70% | 11.7M +48.37% | 7.9M +11.01% | |
Cash Flow | |||||
Cash from Operating Activities | -13.0M +47.80% | -8.8M +3.45% | -8.5M -26.11% | -11.5M +23.47% | |
Capital Expenditures | 60,000 +140.00% | 25,000 -24.24% | 33,000 -60.71% | 84,000 +21.74% | |
Cash from Investing Activities | -72.4M -4,809.43% | 1.5M -22.10% | 2.0M +151.43% | -3.8M -219.87% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 86.2M +986.69% | 7.9M +21.01% | 6.6M +51.67% | 4.3M N/A | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | -597.37% -3.50% | -619.01% +13.31% | -546.29% -38.30% | -885.40% +16.94% | |
Return on Assets | N/A N/A | N/A N/A | -120.24% +20.10% | -100.12% +90.48% | |
Return on Equity | N/A N/A | N/A N/A | -182.19% +49.91% | -121.53% +107.81% | |
Revenue Growth | 31.42% +665.88% | 4.10% -79.76% | 20.27% N/A | 0.00% N/A | |
Current Ratio | 23.33 +886.43% | 2.37 +13.06% | 2.09 -50.89% | 4.26 -46.77% | |
Cash Ratio | 1.14 -9.67% | 1.27 +94.19% | 0.65 -44.77% | 1.18 -82.64% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow